Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Total Debt / (EBITDA-CAPEX)

Adverum Biotechnlgs Total Debt / (EBITDA-CAPEX) Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Total Debt / (EBITDA-CAPEX) from 2013 to 2020.
  • Adverum Biotechnlgs Total Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $0m a -23.16% increase of 0m year over year
  • Adverum Biotechnlgs Total Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $0m a -42.61% increase of 0m year over year
  • Adverum Biotechnlgs Annual Total Debt / (EBITDA-CAPEX) for 2019 was $0m a 98.98% decrease of 0m from 2018
  • Adverum Biotechnlgs Annual Total Debt / (EBITDA-CAPEX) for 2018 was $0m a -93.60% increase of 0m from 2017
  • Adverum Biotechnlgs Annual Total Debt / (EBITDA-CAPEX) for 2017 was $0m a 81.61% decrease of 0m from 2016
Other Ratios Metrics:
  • Adverum Biotechnlgs Total Debt / Capital for the quarter ending December 12, 2017 was $0m a 56.92% increase of 0m year over year
  • Adverum Biotechnlgs Other Liabilities for the quarter ending December 12, 2018 was $2m a -14.42% decrease of 0m year over year
  • Adverum Biotechnlgs Total Debt / Equity for the quarter ending December 12, 2017 was $0m a 56.98% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Total Debt / (EBITDA-CAPEX) Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
12/2017$0m
09/2017$0m
06/2017$0m

Annual ADVM Total Debt / (EBITDA-CAPEX) Data

2019$0m
2018$0m
2017$0m
2016$0m
2012$0m